Characterisation of a Swedish cohort with orofacial granulomatosis with or without Crohn's disease

Oral Diseases

Volumn 21, Issue 1, 2015, Pages e98-e104

  Gale, G ^a   Ostman S ^a   Rekabdar, E ^a   Torinsson Naluai, A ^a   Hogkil K ^b   Hasseus B ^a   Saalman, R ^c   Jontell, M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Eastman Dental Institute Stockholm   (Sweden)

^c SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Clinical characterisation; Inflammatory bowel disease; Mucosal diseases; NOD2; Oral mucosa

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CROHN DISEASE; DEMOGRAPHY; DISEASE DURATION; FEMALE; GENETIC POLYMORPHISM; HUMAN; MALE; MOUTH LESION; ORAL BIOPSY; OROFACIAL GRANULOMATOSIS; PRIORITY JOURNAL; SCHOOL CHILD; YOUNG ADULT; CASE CONTROL STUDY; COMPLICATION; GENETICS; GENOTYPE; PATHOLOGY; SWEDEN;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CROHN DISEASE; FEMALE; GENOTYPE; GRANULOMATOSIS, OROFACIAL; HUMANS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; SWEDEN; YOUNG ADULT;

EID: 84919460502     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12236     Document Type: Article

References (27)

1. Al Johani KA, Moles DR, Hodgson TA, Porter SR, Fedele S (2010). Orofacial granulomatosis: clinical features and long-term outcome of therapy. J Am Acad Dermatol 62: 611-620.
2. Apaydin R, Bahadir S, Kaklikkaya N, Bilen N, Bayramgurler D (2004). Possible role of Mycobacterium tuberculosis complex in Melkersson-Rosenthal syndrome demonstrated with Gen-Probe amplified Mycobacterium tuberculosis direct test. Australas J Dermatol 45: 94-99.
3. Armstrong DK, Biagioni P, Lamey PJ, Burrows D (1997). Contact hypersensitivity in patients with orofacial granulomatosis. Am J Contact Dermat 8: 35-38.
4. Campbell HE, Escudier MP, Patel P, Challacombe SJ, Sanderson JD, Lomer MC (2011). Review article: cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosis. Aliment Pharmacol Ther 34: 687-701.
5. Cleynen I, Gonzalez JR, Figueroa C et al (2013). Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 62: 1556-1565.
6. Escher J, Amil Dias J, Bochenek K et al (2005). Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 41: 1-7.
7. Freysdottir J, Zhang S, Tilakaratne WM, Fortune F (2007). Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis 13: 439-445.
8. Gibson J, Wray D (2000). Human leucocyte antigen typing in orofacial granulomatosis. Br J Dermatol 143: 1119-1121.
9. Gibson J, Wray D, Bagg J (2000). Oral staphylococcal mucositis: a new clinical entity in orofacial granulomatosis and Crohn's disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 171-176.
10. Giovannetti A, Mazzetta F, Cavani A et al (2012). Skewed T-cell receptor variable beta repertoire and massive T-cell activation in idiopathic orofacial granulomatosis. Int J Immunopathol Pharmacol 25: 503-511.
11. Hegarty A, Hodgson T, Porter S (2003). Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 576-585.
12. Hugot JP, Chamaillard M, Zouali H et al (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
13. Ivanyi L, Kirby A, Zakrzewska JM (1993). Antibodies to mycobacterial stress protein in patients with orofacial granulomatosis. J Oral Pathol Med 22: 320-322.
14. Jontell M, Mattsson U, Torgersson O (2005). MedView: an instrument for clinical research and education in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 55-63.
15. Lim SH, Stephens P, Cao QX, Coleman S, Thomas DW (1997). Molecular analysis of T cell receptor beta variability in a patient with orofacial granulomatosis. Gut 40: 683-686.
16. McCartan BE, Healy CM, McCreary CE, Flint SR, Rogers S, Toner ME (2011). Characteristics of patients with orofacial granulomatosis. Oral Dis 17: 696-704.
17. Ogura Y, Bonen DK, Inohara N et al (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
18. Patel P, Barone F, Nunes C et al (2010). Subepithelial dendritic B cells in orofacial granulomatosis. Inflamm Bowel Dis 16: 1051-1060.
19. Patel P, Brostoff J, Campbell H et al (2013). Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy 3: 26.
20. Saalman R, Mattsson U, Jontell M (2009). Orofacial granulomatosis in childhood-a clinical entity that may indicate Crohn's disease as well as food allergy. Acta Paediatr 98: 1162-1167.
21. Sanderson J, Nunes C, Escudier M et al (2005). Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease? Inflamm Bowel Dis 11: 840-846.
22. Savage NW, Barnard K, Shirlaw PJ et al (2004). Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease. Clin Exp Immunol 135: 483-489.
23. Stosiek N, Simon M Jr, Meisel-Stosiek M, Hornstein OP (1987). HLA typing in patients with Melkersson-Rosenthal syndrome. Z Hautkr 62: 1479-1482.
24. Takada K, Ina Y, Noda M, Sato T, Yamamoto M, Morishita M (1993). The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol 46: 359-366.
25. Tilakaratne WM, Freysdottir J, Fortune F (2008). Orofacial granulomatosis: review on aetiology and pathogenesis. J Oral Pathol Med 37: 191-195.
26. Wiesenfeld D, Ferguson MM, Mitchell DN et al (1985). Oro-facial granulomatosis-a clinical and pathological analysis. Q J Med 54: 101-113.
27. Zbar AP, Ben-Horin S, Beer-Gabel M, Eliakim R (2012). Oral Crohn's disease: is it a separable disease from orofacial granulomatosis? A review. J Crohns Colitis 6: 135-142.